A Dermatologist Is Begging People To Wash This 'Often Neglected' Body Part
For some people, showering and bathing isn't just a way to get clean; it's a form of self-care (you've heard of the "everything shower," right?). Their shelves are stocked with a variety of luscious-smelling products, and they'll splurge for the expensive shampoo. Other people are quick with their rinses, seeing washing off as a basic necessity or chore; they're in and out.We're all different, and we all have different approaches to getting clean. Regardless of what type of bath or shower you choose or when you prefer to rinse off—there's a bit of a divide between those of us who like to shower in the mornings, and those who prefer the nighttime—there's a good chance that you're forgetting to wash one specific body part, and it can lead to some pretty gross health problems.
🩺SIGN UP for tips to stay healthy & fit with the top moves, clean eats, health trends & more delivered right to your inbox twice a week💊
A Dermatologist Is Begging People To Wash This 'Often Neglected' Body Part
When was the last time you made a conscious effort to wash your belly button? If you can't remember, that's a problem. 'Belly buttons, even outies but especially innies, are the perfect breeding ground for bacteria. It's dark, damp and often neglected when cleaning,' says Dr. Geeta Yadav, MD, a board-certified dermatologist and founder of FACET Dermatology. Dr. Yadav explains that sweat, dead skin cells, sebum, dirt and debris (like fuzz from clothing) build up in the belly button, giving bacteria plenty of food to thrive. She says that not only can this cause the belly button to develop a foul odor, but it can also cause infections.
Related:
One scientific study found 67 different types of bacteria on the belly buttons of the study participants. Where does it all come from? 'Bacteria is everywhere!' Dr. Yadav says. 'There are 'good' and 'bad' bacteria on our skin at all times, and other factors—like swimming in the ocean, working out at a gym, rewearing dirty clothes or sleeping in used sheets—can introduce new bacteria.'Another scientific study found that the more bacteria a belly button has, the stronger the odor is. PSA: A clean belly button doesn't have a smell. In the most extreme cases of neglect, Dr. Yadav says that umboliths (also spelled 'omphaloliths'), or naval stones, can develop. 'Umboliths are masses made up of sebum, dead skin, hair and other debris that become hard and compacted, similar to an old blackhead. They are not common, but are most likely to form in individuals with very deep 'innie' belly buttons,' she explains.Related:
The Best Way To Keep Your Belly Button Clean
Who knew the humble belly button could get so disgusting, right? Knowing what can happen, chances are you're going to be paying it proper attention from now on. 'Every time you bathe, you should be thoroughly cleaning your belly button with body wash,' Dr. Yadav says.
She says that, typically, using your finger to clean it is adequate (as long as your finger fits in there), explaining, 'Just swirl your finger around inside with body wash, then rinse thoroughly. If you want to be more thorough, you can use a washcloth."
Related:
In terms of what type of cleaning products are best for washing your belly button, Dr. Yadav shares that body wash and your finger are typically all the cleaning tools you need. 'You can also use a liquid chemical exfoliant on a cotton swab if you're concerned about odor and buildup,' she adds. But if you have good hygiene habits, she says that washing your belly button when you wash the rest of your body is enough.
With all this in mind, you should be washing your belly button every time you bathe or shower. That way, you can rest assured there won't be any weird smells coming from it or anything sinister hiding out there that shouldn't be there.
It only takes a few seconds to properly clean the belly button, but it's a crucial few seconds. Give your belly button some undivided attention. That way, it stays healthy and clean.
Up Next: Sources:
Dr. Geeta Yadav, MD, board-certified dermatologist and founder of FACET Dermatology
A Jungle In There: Bacteria in Belly Buttons Is Highly Diverse, but Predictable.PLoS One. 2012
Microbiota in Umbilical Dirt and Its Relationship with Odor. Microbes and Environments. 2023
Omphalolith: An underdiagnosed entity. Clinical Case Reports. 2022
A Dermatologist Is Begging People To Wash This 'Often Neglected' Body Part first appeared on Parade on Jul 20, 2025
This story was originally reported by Parade on Jul 20, 2025, where it first appeared.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNET
19 minutes ago
- CNET
Is Trump's Chronic Venous Insufficiency Diagnosis Actually 'Benign'? A Vein Specialist Weighs In
Last Thursday, July 17, the White House announced that President Trump was diagnosed with chronic venous insufficiency (CVI). According to a memo from Dr. Sean P. Barbabella, the president's physician, this diagnosis came after the president noticed mild swelling in his legs. However, Barbabella reports that CVI is "benign" and common in older adults over the age of 70. Trump is 79. Though the doctor's memo summarized that "President Trump remains in excellent health," we were curious to learn more about CVI and whether or not it's as benign as it's being made out to be. For that information, we contacted Khanh Nguyen, DO, chief medical officer of the Center for Vein Restoration. What is chronic venous insufficiency? Plus, CVI causes Chronic venous insufficiency is when your legs' veins don't work as well as they should. "Normally, veins have small valves that help keep blood flowing back up toward the heart," explains Nguyen. "But if those valves become weak or damaged, blood can start to pool in the legs instead of moving upward like it should." The most common causes of CVI, according to Nguyen, are: Aging : "As we get older, our veins and valves naturally weaken." : "As we get older, our veins and valves naturally weaken." Family history : "If close family members have vein problems, you're more likely to develop them, too. Genetics play a significant role in developing venous disease." : "If close family members have vein problems, you're more likely to develop them, too. Genetics play a significant role in developing venous disease." Being overweight : "Extra weight puts more pressure on the veins in your legs." : "Extra weight puts more pressure on the veins in your legs." Sitting or standing for long periods : "This makes it harder for blood to move out of the legs, especially without movement. Blood is constantly fighting against gravity to return to the heart, so walking and activating the calf muscle helps the blood to be pumped back." : "This makes it harder for blood to move out of the legs, especially without movement. Blood is constantly fighting against gravity to return to the heart, so walking and activating the calf muscle helps the blood to be pumped back." Pregnancy : "Increased blood volume and hormone changes can put a strain on the venous system. In addition, the enlarged fetus and uterus also put pressure on the abdomen and pelvis, compressing the veins and impeding blood return, further increasing venous hypertension." : "Increased blood volume and hormone changes can put a strain on the venous system. In addition, the enlarged fetus and uterus also put pressure on the abdomen and pelvis, compressing the veins and impeding blood return, further increasing venous hypertension." Previous blood clots: "A history of deep vein thrombosis (DVT) can damage vein valves and puts a patient at higher risk for developing venous disease." DVT occurs when a blood clot forms in one or more of the body's deep veins, typically in the legs. These various factors can cause an increase in pressure in the leg veins over time, contributing to venous insufficiency. However, Nguyen states that early treatment and lifestyle changes can help manage symptoms and prevent worsening conditions. Chronic venous insufficiency symptoms While CVI symptoms can vary, Nguyen lists common ones as: leg swelling, heaviness, aching, throbbing, restless legs and cramping. Many patients also notice varicose veins and skin changes like darkening or itching around the ankles. In advanced cases, you may even see venous ulcers or open wounds near the lower legs. "Symptoms often worsen after prolonged periods of standing or sitting and improve with leg elevation and the use of compression stockings," states Nguyen. PonyWang/Getty Images Is it true that chronic venous insufficiency is 'benign'? Though Dr. Sean P. Barbabella, Trump's doctor, claims CVI is "benign," Nguyen says that's not the full picture. "While CVI is often labeled 'benign' because it's not life-threatening like arterial disease, it's not a harmless condition," he says. "Left untreated, it can significantly impact quality of life and lead to complications like chronic pain, skin changes, venous ulcers and potentially blood clots." In other words, chronic venous insufficiency isn't something you should ignore. "It's a medical issue that warrants expert attention and treatment, particularly because early intervention can help prevent its progression," Nguyen explains. How is chronic venous insufficiency diagnosed? "CVI is typically diagnosed by taking a thorough history and performing a physical examination followed by a duplex ultrasound, a noninvasive imaging test that visualizes blood flow and evaluates the function of the veins and their valves," says Nguyen. This test allows doctors to confirm venous reflux (when veins struggle to circulate blood back to the heart) and rule out other conditions like deep vein thrombosis. How is chronic venous insufficiency treated? Nguyen reports that CVI is treated with a combination of the following: compression therapy, lifestyle changes and minimally invasive procedures that close off or redirect blood flow from malfunctioning veins. "Today's advanced outpatient treatments typically take under an hour to complete, require little to no downtime, and are covered by insurance when medically necessary," he explains. "Patients can return to their normal routine immediately, with few restrictions." Early CVI diagnosis and treatment are key According to Nguyen, one of the biggest challenges with CVI is that people ignore early symptoms, writing them off as fatigue or aging. This is especially concerning because CVI is treatable, thanks to modern therapies that are effective, safe and fast. "If you're experiencing leg discomfort, swelling or visible veins, don't wait -- early diagnosis and treatment can make a tremendous difference in your longterm leg health and comfort," concludes Nguyen.
CNN
20 minutes ago
- CNN
Is Frozen Produce Healthier Than Fresh? - Chasing Life with Dr. Sanjay Gupta - Podcast on CNN Podcasts
Dr. Sanjay Gupta 00:00:03 Welcome to Paging Dr. Gupta. As you know, this podcast is one of my favorite podcasts because the best health conversations that I've heard often start with simple, honest questions. And that's what we try and address here each week. Kyra's back with us. What do we have first? Kyra Dahring 00:00:23 So first up today, this listener has a question sparked by a recent Chasing Life episode. And honestly, it kind of has me thinking back to that conversation too. Take a listen. Listener Question 00:00:35 I am following up on your episode with Dr. Tim Spector and he talks about 30 vegetables. What would be those 30 vegetables? And are frozen vegetables just as good as fresh vegetables? I've heard that they're better, hold their nutrients, vitamins, etc. Thank you. I look forward to hearing a podcast answering these questions. Dr. Sanjay Gupta 00:01:01 This is a really good question, are frozen vegetables actually healthy, or are they just plan B when fresh isn't available? I'm going to tell you the answer to that, plus really dig into what Dr. Spector meant about 30 vegetables right after this quick break. Dr. Sanjay Gupta 00:01:20 Okay, let's start with the 30 vegetable part of this. Here is a quick refresher of that Chasing Life episode with Dr. Tim Spector... Dr. Tim Spector 00:01:29 What I'm trying to do is give myself the room so I can have 30 different plants during my week. And that's that diversity of plants, which I think is probably the most crucial rule for nutrition. Dr. Sanjay Gupta 00:01:42 'Okay, so what does that mean? First of all, it does not mean you need to eat 30 vegetables a week. What he's really saying is try to eat thirty different plant-based foods each week. That could include vegetables, yes, but also fruits, whole grains, nuts, seeds, legumes, herbs, even some spices. So spinach and kale, for example, that's two. Apples and bananas, that is two more. Lentils, chia, garlic, turmeric, all of it counts. What we're getting at is this idea that really comes from the American Gut Project, which found that people who ate 30 or more different plants a week have more diverse gut bacteria. And that's linked to better digestion, less inflammation, and stronger immunity. So yeah, you want to eat a variety of foods. Again, it doesn't mean 30 different vegetables, but just think about plant-based foods and incorporating at least 30 different plant-based foods into your diet every week. It's not that hard to do. It's important to do, but not enough people do it. Now, onto frozen vegetables. So the short answer to your question, yes frozen veggies are a healthy choice. In many cases, they're just as nutritious as fresh vegetables, and sometimes, importantly, even more so. Here's why: vegetables meant for freezing are picked at their peak ripeness. That's when they're most nutrient rich. They are then typically blanched, which means they are briefly dipped in hot water to stop spoilage, and then they are flash frozen. And that's what locks in most of their nutrients. Now it is true that some heat-sensitive nutrients like vitamin C, that may dip slightly during the blanching process. But overall, studies have shown frozen vegetables, frozen veggies, have nutrient levels that are very similar to fresh and sometimes even higher. Especially if that fresh produce has been sitting around for days. Now, another key point here, frozen veggies are actually really good at holding onto their nutrients. Fresh produce starts losing vitamins the moment they are picked and continues to lose them in transport and storage in your refrigerator. Frozen vegetables don't keep losing nutrients the way fresh ones do. So, frozen vegetables, they're a win. In so many ways, including cost and convenience and variety. They last longer. They're often more affordable, and they can help you get to that 30 plant-based foods a week, even when something's out of season. Do check the labels. Some frozen veggies come with sauces, and that can add a lot of stuff you don't want, unneeded fat and sodium and preservatives. When you're cooking your veggies from frozen, go for lightly steaming or microwaving. Why? To help preserve the nutrients and the texture. There's no need to thaw first. And finally, a simple trick, add a squeeze of lemon after cooking to brighten flavor and also add a little bit of that vitamin C back in that I was talking about earlier. Bottom line, whether your vegetables are fresh or frozen, the goal is imperfection, it's variety. Keep it colorful, mix it up, and yes, frozen definitely counts. Now, coming up. It's become quite popular and makes some pretty remarkable health promises, but what does pink Himalayan salt actually do for you? We have that in just a moment. Dr. Sanjay Gupta 00:05:17 All right, Kyra, what do we have next? Kyra Dahring 00:05:19 Yes, we got this next question from a listener who is wondering about a health trend that some of us might have seen on social media. Here's what she asked. Listener Fran 00:05:28 Hi, my name is Fran and I'm 70 years old. I am calling in to find out about all the studies on pink Himalayan salt. There are people that drink Himalayan salt with lemon water in the morning and what it's good for. Dr. Sanjay Gupta 00:05:44 'Okay Fran, thank you so much for your question about pink Himalayan salt. It's definitely popular right now. I think we have some sitting in our own kitchen. Interestingly the salt primarily comes from a mine in Pakistan near but not in the Himalayas. The pink color comes from trace minerals like iron, calcium, potassium, and magnesium, which some people think makes it healthier than regular table salt. Just a side note by the way, sea salt also contains many of these same minerals. And sure, pink Himalayan salt tends to be less processed than table salt, which is refined, table salt is to remove impurities, they may contain anti-caking agents as well in table salt and oftentimes it's fortified with iodine, a micronutrient that is essential to human health and wellbeing. But here's the thing, those extra minerals that we're talking about in pink Himalayan salt, those minerals that are often at the root of a lot of these health claims. They're really only present in tiny trace amounts, too small to really have any health impact unless you're consuming unrealistic quantities and you shouldn't do that because it's salt and we eat too much salt already. Additionally, many of the minerals that are in pink Himalayan salt in those trace amounts are actually easily obtained from other healthy foods. Now, some of the health claims you may have heard about pink Himalyan salt, improves sleep, balances your body's pH, boosts energy. But the truth is, there's little scientific evidence to support those specific benefits. Now, to be fair, it'd be really hard to do a study like that, but there just isn't the scientific data to support these claims. Now, this idea about adding it to water. That is actually a trend people are doing. It's called sole, sole water. It's made by adding pink salt dissolved in water and often consumed with lemon. People say that it boosts energy, it detoxifies the body, but again, there's not solid science behind those claims. What is important to know again, is that most people already consume way more sodium than they need. So drinking sole water just adds even more sodium into your diet, which can actually have risks, high blood pressure, kidney issues. So bottom line, is pink Himalayan salt better than regular salt? Not really. It's a fine natural option if you prefer it, but it doesn't offer any proven meaningful health advantages, and it does tend to cost more. Plus, as I mentioned, it typically does not contain added iodine, which is really important to your health. So if you're using pink Himalayan salt exclusively, do make sure you're getting your iodine from foods like seafood or dairy or seaweed. In the end, whatever salt you choose, it is still salt. Moderation is key. Hope that helps, Fran! Dr. Sanjay Gupta 00:08:41 'And thanks to everyone who sent in questions, your curiosity, your stories, your voices, I love hearing it, and that's what brings this show to life. So keep it coming. If there's something health-related you've been wondering about, send it to us. We might answer it next week! Record a voice memo, email it to AskSanjay@ or give us a call, 470-396-0832 and leave a message. Thanks for listening. I'll be back next Tuesday.
Yahoo
37 minutes ago
- Yahoo
Biogen to Highlight Scientific Progress Across Alzheimer's Disease at the Alzheimer's Association International Conference 2025
Lecanemab presentations to include long-term Clarity AD data, real-world treatment insights, and a subcutaneous formulation for continued care Presentations on tau to explore its biological role, the development of targeted therapies and biomarkers, and the future integration of these innovations into clinical practice CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced upcoming scientific presentations at the 2025 Alzheimer's Association International Conference (AAIC), taking place July 27-31 in Toronto, Canada. Data on LEQEMBI® (lecanemab) will include 48-month results from the Clarity AD open-label extension, real-world evidence, and new insights into a subcutaneous formulation for maintenance dosing. Presentations on tau will explore tau-targeted therapies and biomarkers, including baseline characteristics of participants from CELIA, a Phase 2 trial evaluating the efficacy, safety, and tolerability of BIIB080, an investigational antisense oligonucleotide (ASO) therapy that targets tau. 'At AAIC, we are sharing data that underscore our ongoing efforts to advance both how Alzheimer's is treated and how care is delivered, including 48-month findings from the LEQEMBI Clarity AD open-label extension and new insights into the potential of subcutaneous maintenance dosing for LEQEMBI. We are also excited to share baseline characteristics from CELIA, our Phase 2 study of BIIB080, an investigational ASO therapy targeting tau,' said Priya Singhal, M.D., M.P.H., Head of Development at Biogen. 'As we deepen our understanding of this complex disease, we remain committed to pushing the science forward and evolving care to better meet the needs of patients and families.' Key Scientific Sessions and Presentations: Lecanemab Clarity AD OLE in Early AD: Initial Findings from 48-Month AnalysisWednesday, July 30, 8:00–8:45 AM ET Lecanemab Subcutaneous Formulation for Maintenance Dosing: The Potential of a New and Convenient Option for Ongoing Treatment in Early Alzheimer's DiseaseWednesday, July 30, 9:00–10:30 AM ET Patient, Care Partner, and Health Care Professional Opinion of the Lecanemab Autoinjector for Subcutaneous DeliverySunday, July 27, 8:00–8:45 AM ET Lecanemab Two Years Post-Approval: Real-World Case Series and Patient Pathway LearningsSunday, July 27, 9:00–10:30 AM ET Indirect Treatment Comparison of ARIA Outcomes for Lecanemab Compared to Donanemab Based on Reported ResultsSunday, July 27, 4:14–5:45 PM ET Innovations in Tau Therapies and Biomarkers for Alzheimer's Disease: Bridging Research and Clinical PracticeWednesday, July 30, 2:00–3:30 PM ET Baseline Characteristics from CELIA: A Phase 2 Study to Evaluate BIIB080 in Participants with Early Alzheimer's DiseaseMonday, July 28, 7:30 AM–4:15 PM ET Educational Program on Tau in Alzheimer's Disease At AAIC, Biogen will host an interactive booth offering an immersive journey into the role of tau in Alzheimer's disease, from pathology to clinical presentation. Biogen is also expanding its educational efforts with a new e-learning module on building on the resources already available. For more information, please see the AAIC 2025 program and visit the Biogen AAIC booth. About BIIB080BIIB080 is an investigational antisense oligonucleotide (ASO) therapy designed to target microtubule-associated protein tau (MAPT) mRNA to reduce the production of tau protein. Abnormal accumulation of tau in the brain is a hallmark of Alzheimer's disease and is associated with neurodegeneration and cognitive decline. BIIB080 is currently being evaluated in a Phase 2 clinical study (NCT05399888) in individuals with early Alzheimer's disease. In December 2019, Biogen exercised a license option with Ionis Pharmaceuticals and obtained a worldwide, exclusive, royalty-bearing license to develop and commercialize BIIB080 (tau ASO). BIIB080 was discovered by Ionis. About LEQEMBI ® (lecanemab)LEQEMBI (lecanemab) is the result of a strategic research alliance between Eisai and BioArctic. LEQEMBI is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble (protofibril) and insoluble forms of amyloid-beta (Aβ). LEQEMBI is an amyloid beta-directed antibody for the treatment for Alzheimer's disease (AD) in the U.S. The U.S. Food and Drug Administration (FDA) granted LEQEMBI traditional approval on July 6, 2023. LEQEMBI is indicated for the treatment of Alzheimer's disease. Treatment with LEQEMBI should be initiated in patients with mild cognitive impairment or mild dementia stage of disease, the population in which treatment was initiated in clinical trials. Eisai and Biogen have been collaborating on the joint development and commercialization of AD treatments since 2014. Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with both companies co-commercializing and co-promoting the product and Eisai having final decision-making authority. Please see full U.S. Prescribing Information for LEQEMBI, including Boxed WARNING and Medication Guide. About BiogenFounded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients' lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term routinely post information that may be important to investors on our website at Follow us on social media - Facebook, LinkedIn, X, YouTube. Biogen Safe Harbor This news release contains forward-looking statements, including about the potential clinical effects of lecanemab and BIIB080; the potential benefits, safety and efficacy of lecanemab and BIIB080; potential regulatory discussions, submissions and approvals and the timing thereof; the treatment of Alzheimer's disease; the anticipated risks, benefits and potential of Biogen's collaboration arrangements with Eisai; the potential of Biogen's commercial business and pipeline programs, including lecanemab and BIIB080; and risks and uncertainties associated with drug development and commercialization. These forward-looking statements may be accompanied by such words as 'aim,' 'anticipate,' 'assume,' 'believe,' 'contemplate,' 'continue,' 'could,' 'estimate,' 'expect,' 'forecast,' 'goal,' 'guidance,' 'hope,' 'intend,' 'may,' 'objective,' 'plan,' 'possible,' 'potential,' 'predict,' 'project,' 'prospect,' 'should,' 'target,' 'will,' 'would,' and other words and terms of similar meaning. Drug development and commercialization involve a high degree of risk, and only a small number of research and development programs result in commercialization of a product. Results in early-stage clinical trials may not be indicative of full results or results from later stage or larger scale clinical trials and do not ensure regulatory approval. You should not place undue reliance on these statements. Given their forward-looking nature, these statements involve substantial risks and uncertainties that may be based on inaccurate assumptions and could cause actual results to differ materially from those reflected in such statements. These forward-looking statements are based on management's current beliefs and assumptions and on information currently available to management. Given their nature, we cannot assure that any outcome expressed in these forward-looking statements will be realized in whole or in part. We caution that these statements are subject to risks and uncertainties, many of which are outside of our control and could cause future events or results to be materially different from those stated or implied in this document, including, among others, uncertainty of long-term success in developing, licensing, or acquiring other product candidates or additional indications for existing products; expectations, plans and prospects relating to product approvals, approvals of additional indications for our existing products, sales, pricing, growth, reimbursement and launch of our marketed and pipeline products; our ability to effectively implement our corporate strategy; risks associated with third party collaborations; the risk that positive results in a clinical trial may not be replicated in subsequent or confirmatory trials or success in early stage clinical trials may not be predictive of results in later stage or large scale clinical trials or trials in other potential indications; risks associated with clinical trials, including our ability to adequately manage clinical activities, unexpected concerns that may arise from additional data or analysis obtained during clinical trials, regulatory authorities may require additional information or further studies, or may fail to approve or may delay approval of our drug candidates; the occurrence of adverse safety events, restrictions on use with our products, or product liability claims; risks of unexpected costs or delays or other unforeseen hurdles; and any other risks and uncertainties that are described in other reports we have filed with the U.S. Securities and Exchange Commission. These statements speak only as of the date of this press release and are based on information and estimates available to us at this time. Should known or unknown risks or uncertainties materialize or should underlying assumptions prove inaccurate, actual results could vary materially from past results and those anticipated, estimated or projected. Investors are cautioned not to put undue reliance on forward-looking statements. A further list and description of risks, uncertainties and other matters can be found in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and in our subsequent reports on Form 10-Q and Form 10-K, in each case including in the sections thereof captioned 'Note Regarding Forward-Looking Statements' and 'Item 1A. Risk Factors,' and in our subsequent reports on Form 8-K. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements whether as a result of any new information, future events, changed circumstances or otherwise. MEDIA CONTACT:BiogenMadeleine Shin+ 1 781 464 INVESTOR CONTACT:BiogenTim Power+1 781 464 2442IR@ Error al recuperar los datos Inicia sesión para acceder a tu cartera de valores Error al recuperar los datos Error al recuperar los datos Error al recuperar los datos Error al recuperar los datos
